Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study of LY3361237 in Participants With Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT03933943

Public ClinicalTrials.gov record NCT03933943. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Randomized, Placebo-Controlled, Multiple- Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3361237 in Patients With Systemic Lupus Erythematosus

Study identification

NCT ID
NCT03933943
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
28 participants

Conditions and interventions

Interventions

  • LY3361237 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 20, 2019
Primary completion
Feb 14, 2021
Completion
Feb 14, 2021
Last update posted
Mar 3, 2021

2019 – 2021

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207
Clinical Research of West Florida Clearwater Florida 33765
Clinical Research of West Florida Tampa Florida 33606
North Georgia Rheumatology, PC Lawrenceville Georgia 30046
DJL Clinical Research, PLLC Charlotte North Carolina 28210
Paramount Medical Research Middleburg Heights Ohio 44130
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
West Tennessee Research Institute Jackson Tennessee 38305
Accurate Clinical Management LLC - Katy Houston Texas 77084

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03933943, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03933943 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →